INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common illicit drugs, they represent a serious public health challenge due to the spike in intoxications and fatalities that have been linked to their use. This study aims to provide epidemiological data on NPS use in the USA, determining lifetime prevalence of use and defining demographic, socioeconomic, drug use patterns and mental health correlates. METHODS: This study uses secondary data from the US National Survey on Drug Use and Health (NSDUH), which is a large cross-sectional population-based survey carried out annually in the USA. We analysed data from 2007-14 (N = 307,935) using bivariate descriptive analysis and binary logistic regression to...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Deligiann...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
Aims: To summarize evidence on the frequency and predictors of health‐care utilization among people...
Introduction: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
IntroductionAs Novel psychoactive substances (NPS) are conceived to mimic the effects of common illi...
Introduction As Novel psychoactive substances (NPS) are conceived to mimic the effects of common ill...
Background: In recent years, there has been an increase in emergence and use of novel psychoactive s...
BackgroundNovel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not co...
Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not ...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study ...
Use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Deligiann...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
Aims: To summarize evidence on the frequency and predictors of health‐care utilization among people...
Introduction: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
IntroductionAs Novel psychoactive substances (NPS) are conceived to mimic the effects of common illi...
Introduction As Novel psychoactive substances (NPS) are conceived to mimic the effects of common ill...
Background: In recent years, there has been an increase in emergence and use of novel psychoactive s...
BackgroundNovel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not co...
Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not ...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study ...
Use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Deligiann...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
Aims: To summarize evidence on the frequency and predictors of health‐care utilization among people...